EXOMIND

🧠 What is EXOMIND?

EXOMIND (or ExoTMS™) is a non-invasive transcranial magnetic stimulation (TMS) therapy by BTL that uses gentle magnetic pulses to stimulate the dorsolateral prefrontal cortex (DLPFC)—a brain area tied to mood regulation, decision-making, and self-control.

The goal is to boost neuroplasticity, helping the brain build stronger neural connections for improved emotional clarity, focus, and resilience

⚙️ Treatment Protocol

Session length: ~25–30 minutes each
Number of sessions: Typically 6 sessions over 1–3 weeks. Some sites offer initial packages of six and may follow up with maintenance visits or extended plans (up to 20–30 sessions) for lasting results
Schedule: Usually 1–3 sessions/week (some protocols spread six sessions over three weeks) .
No downtime: You can walk in, relax (many fall asleep), and resume daily activities immediately after

✅ FDA Clearance & Approved Uses

FDA-cleared for Major Depressive Disorder (MDD) in the U.S.

Also approved in Canada and the EU for anxiety, OCD, and certain eating disorders

📊 Results You Can Expect

Based on clinical data and provider reports:

Depression: ~50% symptom reduction in 4 weeks; ~58% achieve long-term remission; ~65% respond even if resistant to medications.
Mental well-being & mood: ~90% report feeling calmer, less stressed, improved emotional control.
Cognitive benefits: Sharper focus, memory, clarity—especially helpful for treating “brain fog”

Eating behaviors: 78–100% report reduced food cravings, fewer binge‑eating episodes, often with modest weight loss (avg ~4–5 lb in a month)

Comfort & adherence: 85–95% find sessions comfortable; 72% adherence compared to 50–60% for medications